Joint Clinical Assessment (JCA) Dossier Manager, International HTA Strategy
AbbVie
About this role
The role involves leading the development and execution of Joint Clinical Assessment (JCA) dossiers within the framework of the EU HTA regulation. This includes ensuring compliance with regulations, coordinating cross-functional teams, managing timelines, and liaising with external authorities to support market access strategies.
Skills
Qualifications
About AbbVie
abbvie.caAbbVie is a global biopharmaceutical company (spun out of Abbott in 2013) that discovers, develops and commercializes specialty medicines across immunology, oncology, neuroscience, eye care and virology. It is best known for blockbuster brands such as Humira and a growing portfolio that includes targeted biologics and small molecules (and expanded capabilities after the Allergan acquisition). AbbVie emphasizes large-scale R&D, clinical development and strategic partnerships to advance its pipeline and bring therapies to patients worldwide. Headquartered in North Chicago, Illinois, the company operates globally with a focus on long-term innovation and patient outcomes.
About AbbVie
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for AbbVie.
Salary
$130k – $150k
per year
More jobs at AbbVie
Similar Jobs
Joint Clinical Assessment (JCA) Dossier Manager, International HTA Strategy
AbbVie
Joint Clinical Assessment (JCA) Dossier Manager, International HTA Strategy
AbbVie
Director, Market Access, Health Technology Assessment Ops – Hematology (EU)
BeOne Medicines
EU HTA Dossier Lead (m/f/d)
MSD
(Senior) Health Technology Assessment (HTA) Strategy Manager (m/w/d)
Eli Lilly and Company
Executive Director, HTA Strategy, Europe
Revolution Medicines